itraconazole and Cytomegalovirus

itraconazole has been researched along with Cytomegalovirus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C1
Bouza, E; Desco, M; Domínguez, MJ; Muñoz, P; Palomo, J; Rodríguez, C; Yañez, JF1

Other Studies

2 other study(ies) available for itraconazole and Cytomegalovirus

ArticleYear
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
    Journal of medical virology, 2014, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult

2014
Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Cytomegalovirus; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Regression Analysis; Risk; Risk Factors; Time Factors; Treatment Outcome

2004